AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Continuous Positive Airway Pressure, Arousability and Links to Mechanisms in Obstructive Sleep Apnea

RecruitingPhase 3Ages 18 Years - anyAllYale University
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The study design is a randomized, controlled clinical trial to test the hypothesis that arousal threshold (ArTH) will affect how individuals with obstructive sleep apnea (OSA, Apnea-Hypopnea Index (AHI) of 10/hour of higher) respond to CPAP therapy regarding adherence and cognitive function (executive function). Investigators hypothesize that raising ArTH with eszopiclone will improve adherence to CPAP and neurocognitive function with CPAP therapy. Investigators also hypothesize that a lower baseline ArTH is associated with worse CPAP adherence, while a higher baseline ArTH is associated with improved neurocognitive outcomes with CPAP therapy.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Able to provide informed consent. * Clinically confirmed new diagnosis of OSA: 1. Polysomnography AHI โ‰ฅ 10 per hour of sleep and/or 2. Home sleep apnea testing, respiratory even index, REI โ‰ฅ 10 per hour of recording Exclusion Criteria: * Known non-OSA related conditions associated with sleep-disordered breathing (e.g., a central disorder of hypersomnolence, neurological, neuromuscular, or pulmonary disorder) * Use of sleep-inducing medications (e.g., other non-benzodiazepine sedative hypnotic-drugs \[e.g., zoldpidem\], benzodiazepines, non-selective antihistamines, trazodone, opiates, barbituates) * Known hypersensitivity reaction to eszopiclone * Contraindications to its use based on medical history or function (e.g., dizziness at baseline or established mobility problems or imbalance) * History of complex sleep behaviors (e.g., NREM or REM parasomnias) * Concomitant use of โ‰ฅ 2 servings of alcohol per night or other CNS depressant for 2 weeks prior or throughout the study * Sleep opportunity of less than 7 hours * Severe active depression or other mental health disorders (e.g., schizophrenia, bipolar disorder, personality disorder). * History of sleep-walking, sleep-driving, and engaging in other activities while not fully awake * History of motor vehicle accidents related to sleepiness and/or motor vehicle "near misses" (e.g. sleepiness during driving or lane changes) * Severe hepatic impairment (liver function tests 2 X the upper limit of normal) * Unstable medical condition (e.g., decompensated heart failure, end-stage chronic obstructive pulmonary disease, end-stage renal disease) * Females of childbearing potential who are pregnant, breastfeeding, or intend to become pregnant, and women who are in the process of egg donation .
๐Ÿ’Š

What it tests

  • Eszopiclone
  • Placebo
๐Ÿ“

Where

1 site
Yale Centers for Sleep Medicine
North Haven, United States
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy